Navigation Links
Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
Date:11/9/2011

BEIJING, Nov. 9, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today the positive top-line results from its phase II clinical trial for its proprietary inactivated vaccine against human enterovirus 71 (EV71), which causes hand, foot and mouth disease (HFMD).  The preliminary Phase II results for the EV71 vaccine showed a good immunogenicity and a favorable safety profile with no vaccine-related serious adverse event.

The phase II trial was designed as a single center, randomization, double blinded, and placebo controlled study and enrolled 540 healthy volunteers, comprised of infants from six months to thirty-five months old. On November 8, 2011, the unblinding conference for the phase II clinical data was held under the supervision from the Data Safety and Monitoring Committee (DSMC), and was attended by experts from the China State Food and Drug Administration (SFDA) and the China CDC. The phase II clinical results have provided the reference data for phase III clinical trial, including the vaccination schedule and dosage selection, based on which the proper dosage can be selected to enter into the phase III clinical trial. The purpose for the phase III clinical trial is to evaluate the efficacy of protection against HFMD caused by EV71 and is designed as a multi-center, randomized, double-blinded and control study.

Dr. Weidong Yin, Chairman and CEO, remarked, "The positive phase II results are the significant milestone in the development of our EV71 vaccine to address a significant unmet medical need in those area, where the young children are under the high risk of infection. Based on the phase II results, the proper dosage level can be selected to be utilized in the phase III clinical trial. We have started the preparation work for the phase III clinical trial, including dete
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
2. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
3. Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
4. Sinovac Announces Plan to Launch Offering of Common Shares
5. Sinovac Announces Recent Developments
6. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
7. Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive(R)
8. Sinovacs PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric Population
9. Sinovac Files Shelf Registration Statement
10. Sinovac Named One of Chinas Top 10 Most Competitive Companies Listed Overseas in 2009
11. Sinovacs CEO Weidong Yin Nominated for China Central Televisions Prestigious Economic Man-of-the-Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... MAHWAH, N.J. , Aug. 28, 2014  Stryker Orthopaedics, ... Champions Tour, is bringing its message of joint health to ... Playoffs this week at the Deutsche Bank Championship. The company,s ... in the "Fairway Fan Zone on 9" at the TPC ... Thursday, August 28 th .    At the ...
(Date:8/28/2014)... Aug. 28, 2014  Critical Process Filtration, Inc. ... today announces the expansion of their Technical Services ... Filtration now offers customers and potential customers services ... filter failure analyses (even for competitor filters) and ... hallmark services of system benchmarking and cost/performance optimization. ...
(Date:8/28/2014)... --  RapidForce , an innovative muscle support and pain ... professional tennis player John Isner . Currently the ... competitions to help with knee support. He is wearing ... US Open Tennis Championships. Fifteen times ... a revolutionary hybrid of a brace and kinesiology tape. ...
Breaking Medicine Technology:Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5Critical Process Filtration, Inc. Announces Expanded Technical Services and Validation Support 2America's top-ranked tennis player John Isner Joins Forces with RAPIDFORCE Physio Hybrid Shapes 2America's top-ranked tennis player John Isner Joins Forces with RAPIDFORCE Physio Hybrid Shapes 3America's top-ranked tennis player John Isner Joins Forces with RAPIDFORCE Physio Hybrid Shapes 4
... Oxazolidinone Enrolls in Four Months SAN DIEGO, Jan. 26 ... enrollment in its randomized, double-blind Phase 2 clinical trial ... as TR-701) in patients with complicated skin and skin ... in 12 clinical sites in the United States, examined ...
... linked to psoriasis ANN ARBOR, Mich., Jan. 25 Scientists ... Dermatology , the U-M School of Public Health ... how genetic differences among individuals result in psoriasis, an autoimmune ... the findings could lead to new drug targets and tailored ...
Cached Medicine Technology:Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections 2Scientists Unmask Genetic Markers Associated With Psoriasis 2Scientists Unmask Genetic Markers Associated With Psoriasis 3Scientists Unmask Genetic Markers Associated With Psoriasis 4
(Date:8/28/2014)... Albany, New York (PRWEB) August 28, 2014 ... is currently perceived with great interest among other healthcare ... due to the high demand in vaccine with respect ... also highly in demand due to an improved understanding ... individuals across the United States. It has led to ...
(Date:8/28/2014)... New York (PRWEB) August 28, 2014 ... that has spent many years fighting to ensure that ... the decision to provide coverage to WTC victims who ... by the U.S. Government Accountability Office (GAO). According to ... on August 25th, the report is entitled “World Trade ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Hastings and ... has been providing quality accident attorney services and other ... firm is proud to announce that it has saved ... that has been valued at over half of a ... Hastings provides genuine discount attorney's fees that result in ...
(Date:8/28/2014)... News) -- Having greater amounts of yellow pigment in ... objects in hazy conditions, a new study reports. ... hazy conditions in order to test the distance vision ... called macular pigment) in their eyes. The volunteers ... accumulations of the nutrients lutein and zeaxanthin, according to ...
(Date:8/28/2014)... Genetic testing for multiple diseases ... with large reference laboratories as well as smaller ... regard to the genetic variants analyzed, the methods ... to find the most appropriate laboratory providers for ... through these differences, Hayes, Inc. has added GTE ...
Breaking Medicine News(10 mins):Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $23,400 On Settlement Of $540,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $23,400 On Settlement Of $540,000 3Health News:Eye Pigment May Help Vision in Hazy Conditions 2Health News:Hayes, Inc. Unveils Laboratory Comparison Tables for GTE Clients 2
... bone marrow transplants are not the best option for ... fail to attain clinical remission after the initial weeks ... largest study ever of such pediatric ALL patients identified ... rates of 72 percent after additional chemotherapy rather than ...
... HealthDay Reporter , WEDNESDAY, April 11 (HealthDay News) -- ... could result in some of the changes to a ... researchers report. Participants in the small study who ... night and who were subjected to shifting sleep-wake cycles ...
... The demand for caregivers is growing rapidly as California,s population ... or near-poverty wages and have poor access to health care ... Health Policy Research has found. Fifty-seven percent ... 450,000 paid caregivers in the state have incomes that ...
... Reporter , TUESDAY, April 10 (HealthDay News) -- The upcoming ... than one for Americans: A new study suggests that fatal ... last-minute filers carelessly rushing to the post office to mail ... indicates that "stressful deadlines lead to driver distraction and human ...
... SEATTLE, Washington, April 9, 2012 The Life Sciences ... awards to three Washington non-profit organizations to foster ... Two of the grants focus on infectious disease. ... will assess the effectiveness of a novel material ...
... excerpts from an interview with Dr. C. Daniel Smith describing the ... Blog . JACKSONVILLE, Fla. Mayo Clinic in ... in the United States to offer a newly approved device to ... as acid reflux disease , can lead to serious health ...
Cached Medicine News:Health News:Chemotherapy proves life-saving for some leukemia patients who fail induction therapy 2Health News:Chemotherapy proves life-saving for some leukemia patients who fail induction therapy 3Health News:Disrupted Sleep May Raise Risk for Obesity, Diabetes: Study 2Health News:Disrupted Sleep May Raise Risk for Obesity, Diabetes: Study 3Health News:Majority of California's Medi-Cal caregivers live in or near poverty 2Health News:Majority of California's Medi-Cal caregivers live in or near poverty 3Health News:Tax Day May Drive Up Fatal Crash Rates 2Health News:Tax Day May Drive Up Fatal Crash Rates 3Health News:Washington's Life Sciences Discovery Fund awards commercialization grants 2Health News:Mayo Clinic offers newly approved treatment for acid reflux disease 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: